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The incidence of allergic diseases in childhood appears to have significantly increased
over the last decades. Since environmental factors, including diet, have been thought
to play a significant role in the development of these diseases, there is great
interest in identifying prevention strategies related to early nutritional interventions.
Breastfeeding is critical for the immune development of newborns and infants through
immune-modulating properties and it impacts the establishment of a healthy gut
microbiota. However, the evidence for a protective role of breastfeeding against the
development of food allergy in childhood is controversial, and there is little evidence
to support the benefits of an antigen avoidance diet during lactation. Although it is
not possible to draw a definitive conclusion about the protective role of breast milk
against allergic diseases, exclusive breastfeeding is still recommended throughout the
first 6 months of life due to associated health benefits. Furthermore, recommendations
regarding complementary feeding in infancy have been significantly modified over the last
few decades. Several studies have shown that delayed exposure to allergenic foods does
not have a role in allergy prevention and recent guidelines recommend against delaying
the introduction of complementary foods after 6 months of age, both in high- and low-risk
infants. However, trials investigating this dietary approach have reported equivocal results
so far. This review summarizes the available high-quality evidence regarding the efficacy
of the principal dietary interventions proposed in early life to prevent allergic diseases
in children.
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INTRODUCTION
Environmental exposures, such as nutritional intake during the critical stages of pregnancy and in
the early postnatal period, play a significant role in the development of infant immune system and
it has been suspected that may also be involved in the origin of childhood atopic diseases (1).
Many studies have investigated the association between maternal diet and the development
of childhood allergic diseases, however, to date, the results have been largely inconclusive and
controversial (2). Exclusive breastfeeding is recommended throughout the first 6months of life, due
to associated health benefits, but it is also apparent that breastfeeding should be continued beyond 6
months after the introduction of complementary foods (CF). Duration of breastfeeding rather than
exclusivity may be important in prevention of allergic diseases. Nonetheless, while the evidence
for a protective role of breastfeeding against the development of food allergy is controversial, the
recommendations regarding introduction of complementary foods in infancy have significantly
changed over the last decades.
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This mini review summarizes the current high-quality
evidence regarding the principal early life dietary interventions in
preventing allergic diseases in children, particularly in regard to
maternal diet during pregnancy, breastfeeding, and introduction
of complementary foods.
MATERNAL DIET DURING PREGNANCY:
DOES IT INFLUENCE THE RISK OF
ALLERGIC DISEASES IN OFFSPRING?
Maternal diet during pregnancy represents the earliest nutritional
exposure to allergens for the fetus. Most studies to date have
demonstrated an equivocal correlation between maternal diet
during pregnancy and the development of childhood allergic
diseases. A Cochrane systematic review did not support allergen
avoidance or nutrient supplementation during pregnancy as a
means to prevent allergic diseases in offspring (3). However,
evidence from mother consumption of peanut and tree nuts
suggests that fetal allergen exposure through maternal diet may
actually increase tolerance and reduce risk of developing these
childhood food allergies (4). Therefore, further studies are needed
to elucidate the role of maternal nutrition in the development of
food allergies in offspring.
Fatty Acids
A causal relationship between early maternal consumption of
polyunsaturated fatty acids (PUFAs) and childhood allergic
diseases is debated (5). The T-helper shift from type 1 to
type 2 may derive from a higher n-6: n-3 fatty acids ratio
during pregnancy, leading to an increased risk of allergic
rhinitis in offspring (6). It is thought that N-3 PUFAs probably
limit cytokine cascade (7), decrease n-6 PUFA inflammatory
effects, regulate T cell function (cell membrane fluidity,
signaling, and gene transcription), and promote long-term effects
through epigenetic mechanisms (8). Therefore, daily maternal
supplementation of n-3 PUFAs could reduce the risk of food
allergies and IgE-associated eczema in infants with a family
history of allergy (9). However, findings about the role of n-3
PUFA supplementation in pregnancy for reducing the overall
incidence of allergic outcomes in offspring are still insufficient.
Antioxidants
Antioxidants (i.e., vitamin E, flavonoids, selenium, and copper)
intake during pregnancy may be beneficial, as they have
immunomodulatory properties and could play a role on fetal lung
development and on respiratory health later in life, thus reducing
the risk of wheezing (10).
Vitamin D
The association between vitamin D status of pregnant women
and the development of atopic diseases in childhood is not
clear. For this reason, prenatal vitamin D supplementation for
the prevention of allergic diseases in offspring is not currently
recommended. We know 25-hydroxyvitamin D3 levels in cord
blood are directly associated with lower mononuclear cell
cytokine responses to allergens and reduced risk of eczema in the
first 12 months of life (11). In addition, higher vitamin D intake
during pregnancy has been associated with lower risk of wheezing
and eczema in offspring at 16–24 months of age (12). However,
follow-up of the same cohort showed an increased risk of eczema
later in life (13). The immunomodulatory mechanism of vitamin
D seems to have an influence on Th2 cells differentiation, but its
benefits are still unclear and the literature is conflicting (14).
Foods
A recent prospective birth cohort study showed an association
between prenatal maternal intake of certain foods and the risk of
allergic diseases in offspring by the age of 3 years (10). Namely,
consumption of green vegetables, eggs, and grains were found to
play a protective role against respiratory allergic diseases, whereas
higher meat intake in the preconception period was positively
associated with an increased risk of wheezing, allergic rhinitis,
and eczema. In a previous prospective cohort study, a diet rich
in vegetables during pregnancy has been associated with reduced
risk of childhood asthma in offspring (15). A systematic review
and meta-analysis concluded that maternal fish consumption
during pregnancy did not reduce the risk of allergic outcome in
offspring (16).
BREASTFEEDING: DOES HUMAN MILK
PLAY A PROTECTIVE ROLE?
Current guidelines recommend human milk (HM) as the “gold
standard” for infant nutrition (17). Breastfeeding prolongs
the interaction with the mother’s immune system and may
influence oral tolerance and the risk of allergies in childhood.
Pivotal studies clearly confirm the relevant role of breastfeeding
for short-term infant health (e.g., growth, immune function,
protection against infections) as well as for potential long-term
advantages (e.g., neurocognitive development, prevention
of malignancies, and non-communicable diseases) (18).
Nevertheless, the evidence for the role of HM for the prevention
of allergic diseases remains limited and controversial. This
is due to variable definitions of allergic outcomes and to the
lack of randomized controlled trials with detailed information
about the maternal diet in breastfeeding. While many studies
emphasize a protective effect, others even suspect HM may
promote allergies (19). The balance between oral tolerance and
skin sensitization may affect food allergy risk among infants
with eczema: additional evidence suggests that colostrum has
a prophylactic role in maintaining oral tolerance, but in case
of severe cutaneous barrier dysfunction the protective effect
of prolonged breastfeeding is lost (20). Early oral exposure to
aeroallergens through HM intake could increase the risk of
sensitization in offspring (21). On the other hand, exclusive
breastfeeding seems to reduce the incidence of eczema in the first
2 years of life and the risk of asthma in the first 5 years (22, 23),
or even 10 years with weaker evidence (24).
Several reasonable explanations account for HM protective
effects on allergy susceptibility in children: stimulation of
immune development (direct interactions with infant immune
cells), epigenetic actions (DNA methylation, and non-coding
RNAs), modulation of gut microbiota.
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Breast milk is a living tissue and various bioactive factors
appear to be involved. For instance, TGF-β is a regulatory
cytokine crucial for long-lasting Treg-mediated food tolerance
(25). Maternal antigen immune complexes (IgG-IC) in breast
milk may interact with the neonatal crystallizable fragment
receptor (FcRn) on infant dendritic cells (26), favoring oral
tolerance. In addition, breast milk contains up to 105 bacterial
cells/ml: HM microbiota plays a role in bacterial colonization
of the infant intestinal tract that could contribute to modulate
allergy susceptibility early and later in life. Finally, human milk
oligosaccharides (HMOs) can play a key role in neonatal mucosal
and systemic immunity. HMOs represent an antimicrobial
barrier acting as soluble decoy receptors that block adhesion
of various pathogens, promote intestinal development, and
stimulate immunomodulation acting as signal molecules for the
host cells. Some HMOs have been proven to play a crucial
role in shaping gut microbiota and regulating early life immune
development, but the precise mechanism is currently unknown.
Furthermore, specific HMOs profiles have been associated with
lower risk of cow’s milk allergy (27).
Different formulas are available for newborns and infants who
cannot be breastfed. Among them, hydrolyzed formulas have
been specifically proposed for infants at risk of allergies; however,
their role in allergy prevention is still under debate (28).
COMPLEMENTARY FEEDING: DOES
TIMING OF FOOD INTRODUCTION
INFLUENCE THE RISK OF ALLERGIES?
In past years, it has been traditionally recommended to delay
the introduction of foods recognized as potentially allergenic,
based on the theory that the gut structural and functional
immaturity and increased permeability determines an increased
risk of allergic sensitization (29). Nevertheless, early exposure to
these allergens may be critical to achieve food tolerance, which
is an antigen-driven process as suggested by animal models (30).
According to the so-called “dual-allergen exposure hypothesis,”
oral administration of food allergens favors the establishment of
tolerance via the expansion of Th1 and Treg populations, whereas
exposure to food allergens through skin barrier disruptions favors
sensitization via Th2 switch and cytokines production (29).
Current evidence suggests that oral allergen exposure may
start at 4months onwards, although proper timing of this “critical
window” is still not clear (31).
In 2016, the Enquiring About Tolerance trial showed that, in
a general population of exclusively breastfed infants, the early
(i.e., between 3 and 6 months of age) introduction of potentially
allergenic foods (cow’s milk, cooked egg, peanut, fish, wheat,
and sesame) was effective for prevention of food allergy (32).
In particular, while the incidence of food allergy at 3 years of
age was not significantly different between the early introduction
group compared to the control group in the intention-to-treat
analysis, the per-protocol analysis showed a significant reduction
of overall incidence of food allergy, peanut allergy, and egg
allergy in the early introduction group. However, the high rate
of non-adherence in the early introduction group (68.1%) limits
the reliability of the study results. Results from the Learning
Early About Peanut Allergy trial suggested that peanut should
be introduced between 4 and 11 months in infants at high risk
for allergy (33). According to a recent systematic review, this
practice may reduce the risk of peanut allergy, with the strongest
evidence supporting a benefit to high risk infants (i.e., with
severe atopic dermatitis or egg allergy) but it is also applicable
to infants at lower risk (34). In addition to these findings, there is
limited high quality evidence suggesting the lack of a relationship
between consumption of peanut during weaning and the risk of
atopic dermatitis/eczema and asthma, while not enough evidence
supports the causal relationship between consuming peanut and
developing allergic rhinitis at 2, 5, or 6 years of age (34).
Many studies addressing the effect of egg introduction on
the risk of developing allergy, have provided conflicting results.
This is likely due to unaccounted variables from different study
populations, as well as variations in dose and form of the eggs
used (raw or cooked) (35–39). However, a recent systematic
review provided moderate evidence that introducing egg at 4–6
months of age may reduce the risk of developing egg allergy (34).
In the same study, limited evidence showed the lack of association
between the timing of egg introduction and the development of
atopic dermatitis/eczema and asthma, while not enough evidence
supported a relationship with risk of allergic rhinitis in the first 5
years of life (34).
Previous observational studies have also investigated the effect
of the timing of fish introduction on the risk of allergic diseases
(40, 41). A recent systematic review provided limited evidence to
suggest that the introduction of fish between 3 and 8 months of
life may lower the risk of atopic dermatitis/eczema (34). However,
at present there is not enough evidence of a link between fish
consumption and food allergy, asthma, or allergic rhinitis (42).
With regard to cow-milk, while previous observational studies
reported conflicting results on the risk of cow’s milk allergy
(43, 44), more recently a randomized clinical trial demonstrated
that the risk of sensitization to cow’s milk as well as the
risk of immediate food allergy were decreased by avoiding
supplementation with cow’s milk formula for at least the first
3 days of life (45). In addition, a recent systematic review
provided limited high quality evidence suggesting the lack of a
relationship between age of introduction and risk of food allergy
and atopic dermatitis/eczema. However, there was not enough
evidence to support an association between cow’s milk formula
supplementation and the development of asthma and allergic
rhinitis (34).
Overall, these findings suggest that there is not a clear
optimal timing of introduction of potential allergenic foods
for preventing allergic diseases, either for infants in the
general population or for high-risk infants (Table 1). The latest
recommendations issued by the World Health Organization
(46), the American Academy of Pediatrics (22), the European
Academy of Allergy and Clinical Immunology (47), the
European Society for Paediatric Gastroenterology Hepatology
and Nutrition (30), the European Food Safety Authority (48),
and the British Society for Allergy, and Clinical Immunology
(49) have all emphasized the lack of scientific data to support
the introduction of the commonly acknowledged allergenic foods
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TABLE 1 | Timing of introduction of CF and risk of allergic diseases in childhood.
Type of CF Allergic disease
Food allergy Atopic dermatitis/eczema Asthma Allergic rhinitis
Peanut Introduction between 4 and 11
months may decrease the risk of
peanut allergy in infants at high and
low risk (34*, 35#)
No relationship between
consumption during weaning
and the risk of atopic
dermatitis/eczema (35#)
No relationship between
consumption during weaning
and the risk of asthma (35#)
No relationship between
consumption during weaning
and developing allergic rhinitis
(35#)
Egg Introduction between 4 to 8 months
does not prevent egg allergy in high
risk-infants (37*, 39*)
Introduction between 4 to 6 months
does not prevent egg allergy in low
and high risk-infants (36*, 38*)
Introduction between 3 to 9 months
is effective in preventing egg allergy in
high risk-infants (40*)
Introduction between 4 and 6 months
may decrease the risk of allergy to
egg (35 #)
No relationship between
consumption during weaning
and the risk of atopic
dermatitis/eczema (35#)
No relationship between
consumption during weaning
and the risk of asthma (35#)
No relationship between
consumption during weaning
and developing allergic rhinitis
(35#)
Fish Fish consumption during weaning is
not associated with increased risk of
food allergy (35#)
Introduction between 3 and 8
months of age may decrease the
risk of atopic dermatitis/eczema
(35#, 42§)
No relationship between
consumption during weaning
and the risk of asthma (35#, 43#)
Introduction before 9 months of
age may reduce the risk of
allergic rhinitis (41§)
No relationship between
consumption during weaning
and the risk of allergic rhinitis
(35 #)
Cow-milk products Introduction within the first few days
of life is associated with an increased
risk of developing cow’s milk allergy
(44§)
Introduction within the first 2 weeks of
life reduces the risk of cow’s milk
allergy, whereas introduction between
4 to 6 months increased this risk
(45§)
Avoiding supplementation with cow’s
milk formula for at least 3 days of life
decreases the risk of cow’s milk
allergy (46*)
No relationship between age of
introduction and risk of food allergy
(35 #)
No relationship between age of
introduction and risk of atopic
dermatitis/eczema (35#)
No relationship between age of
introduction and risk of asthma
(35#)
No relationship between age of
introduction and risk of allergic
rhinitis (35#)
§observational study.
*randomized control study.
#systematic review.
before 4 months of age, but also the absence of evidence
to justify a delayed introduction of CF after 6 months of
age to prevent allergy, both in high and low-risk infants
(Supplementary Table 1).
DIET-INDUCED CHANGES IN GUT
MICROBIOTA: DO THEY INFLUENCE
ALLERGY RISK?
Pregnancy
Evidence suggests that early life gut microbial dysbiosis
precedes atopy development and that the gut microbiota of
allergic children may show a depleted diversity (50, 51). In
particular, a reduction of certain bacteria (e.g., Bifidobacterium,
Akkermansia, and Faecalibacterium) could drive CD4+ cell
dysfunction, thereby increasing the risk of atopic diseases (52).
It has been recently suggested that diet during pregnancy may
indirectly affect tolerance acting on the microbiota diversity.
In particular, fiber consumption appears to lead to changes
in the maternal gut microbiota metabolism by increasing
the production of short-chain fatty acids (SCFAs), which
represent the first metabolites of gut commensal microbiota.
Therefore, SCFAs that cross the placenta, influence gene
transcription in fetal lung and enhance oral tolerance to
allergens by promoting epithelial integrity, T regulatory (Treg)
cell differentiation, and IgA release from plasma cells, with
long-lasting effects on health (53). Furthermore, it seems that
Frontiers in Pediatrics | www.frontiersin.org 4 August 2020 | Volume 8 | Article 448
Ferrante et al. Early Life Nutrition and Allergy
FIGURE 1 | Early life nutrition and prevention of allergic diseases. Maternal diet during pregnancy and lactation and introduction of complementary foods may
influence susceptibility to allergic diseases through several diverse mechanisms.
fetal Treg cells may be informed by substantial numbers of
maternal cells crossing the placenta and inducing antigen-
specific tolerance. In utero transfer of microbial antigens during
fetal development would enable a balanced immune response
of the newborn to the rapidly developing microbiota post-
partum (54).
Early Life
In recent years there has been increased scientific interest and
studies into the role of CF introduction to the infant diet and the
risk of allergy. Investigations have sought to determine if there
is a cause–effect relationship between diet-induced changes of
infant’s microbiota and the development of allergic diseases.
Indeed, during weaning, a dramatic change of intestinal
microbiota occurs, which is reflected in the transitioning nature
of stool composition (55). Thus, it has been suggested that
the resident microbiota of the gastrointestinal tract, interacting
with solid foods, may be able to modulate the immune system
development in early life (56).
In breastfed infants, a rapid rise in the number of
Enterobacteria and Enterococci has been demonstrated (57),
along with an increased amount of Bifidobacterium and
Lactobacillus spp. (58). Conversely, in formula-fed infants, a
greater abundance of Bacteroides and Clostridium spp. has
been observed, this difference could have implications for
the subsequent development of atopic diseases (57, 58). The
introduction of CF drives the gut microbiota composition
favoring bacteria within the Bacteroidetes and Firmicutes phyla
(58). Most of the reported changes in gut microbiota appear to
occur after weaning, from age 9–18 months until the 3rd year
of life, when the microbiota stabilizes resembling the adult one
(59). Therefore, the window of opportunity for modulating the
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intestinal microbiota composition extends up to the first 2 years
of life, conversely any dysbiosis in this period could determine
an abnormal immune system activation, possibly leading to the
development of pathological conditions such as allergy (56).
It has been hypothesized that a more diverse diet leads to
a more diverse gut microbiota, which may improve the gut
wall integrity and the immune system regulation, supporting the
expansion of Treg cells (60), and suppressing IgE levels (61).
Indeed, a lower microbiota diversity with an increased number
of Firmicutes vs. of Bacteroidetes, has been observed in children
with food sensitization (62). An increased microbial diversity
along with the relative abundance of certain bacteria, such as
Lactobacillus spp. (63), has been correlated with a lower risk
of IgE-associated allergic diseases, namely atopic dermatitis and
wheezing, through a decreasing Th2-mediated response (64). No
significant association between the diversity of complementary
foods and allergic rhinitis has been found so far (65).
According to these findings, early infancy does appear
as a window of opportunity during which diet intervention
may shape the risk of allergic diseases by modulating the
composition of the gut microbiota (60). In this context, it has
been demonstrated in a murine model that dietary fiber intake
leads to marked suppression of the induction of airway allergic
disease, by enhancing Treg cell number and function (66). A
possible explanation is that SCFAs, which would seem to reduce
airway inflammation even in humanmodels, are produced by the
microbiota through the metabolism of dietary fibers (65).
A protective effect against the risk of allergic diseases might
be also derived from the supplementation with prebiotics which
can indirectly promote the production of anti-inflammatory
cytokines by increasing the number of Lactobacillus and
Bifidobacterium spp. (67). Finally, it has been suggested that
adequate levels of vitamin D during the 1st year of life may
lower the risk of developing food allergies, by modulating the
gut microbiota composition (68), with increased Lachnospiraceae
and reduced Lactococcus spp. (69).
Overall, these studies have contributed to deepening our
knowledge about gut microbiota diversity and species-specific
changes. Unfortunately, however, how to manipulate the
intestinal microbiota for the prevention of allergic diseases is still
a matter of debate.
CONCLUSIONS
The link between early dietary factors and the development of
allergy later in life is still not clear. Many dietary factors, from
prenatal life through infancy, have been proposed to influence
the susceptibility to allergic diseases, by modulating the gut
microbiota composition and promoting tolerance to allergens.
None of these, other than early introduction of allergens, has been
proven effective (Figure 1).
Current high-quality evidence for the efficacy of the principal
dietary interventions demonstrates that maternal avoidance of
allergenic foods during pregnancy and lactation is not effective
in preventing allergic diseases. Some evidence suggests that a
maternal diet rich in fibers, antioxidants, and n-3 PUFAs might
promote a protective immunomodulatory role, also mediated by
changes in microbiota. However, further studies are needed to
elucidate the role of maternal nutrition in the development of
food allergy in offspring.
Evidence for an overall protective role of breastfeeding against
allergic diseases is still controversial, even though exclusive
breastfeeding is recommended as the “gold standard” for infant
nutrition during the first 6 months of life.
With regard to complementary feeding, there is no clear
evidence to support a specific timing to the introduction of
potentially allergenic foods for preventing allergic diseases, either
for infants in the general population or for high-risk infants.
Nonetheless, complementary feeding should not be delayed after
6 months of age, nor should breastfeeding be discontinued.
The diversity of the intestinal microbiota in early life is likely
associated with a reduced risk of allergies. Indeed, it has been
suggested that poor gut microbial diversity may increase the risk
of developing allergic diseases. Thus, early infancy does appear as
a window of opportunity during which dietary intervention may
influence the risk of allergic diseases.
To better identify efficacious dietary strategies for primary
prevention of allergies in childhood, future research should
implement longitudinal interventional studies in cohorts of
pregnant women and their offspring, as well as randomized
controlled trials to clarify the potential role of complementary
foods and their optimal timing of introduction.
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